NICOLE CASELLI: Open Payments
NPI 1245609171 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 14 payments from 10 companies in 2025. Trend: 2023 $811 · 2024 $1,124 · 2025 $1,586
Food & beverage: $1,586
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $373 |
| Gilead Sciences, Inc. | 2 | $253 |
| Novo Nordisk Inc | 2 | $242 |
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
| Verona Pharma, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Dexcom, Inc. | 1 | $95 |
| Axsome Therapeutics, Inc. | 1 | $59 |
| Hologic Sales and Service, LLC | 1 | $55 |
Products named: FASENRA, GVOKE HYPOPEN, Ohtuvayre, Epclusa, AIRSUPRA, KRYSTEXXA, VOQUEZNA, Ozempic.
Industry payments across DE — which companies pay providers there.
